Less common activating mutations of FGFR1, such as N546K and K656E, have been identified in dysembryoplastic neuroepithelial tumor (DNET),6 small cell lung cancer (SCLC),7 Ewing sarcoma,8 and in other cancers.9 Here, FGFR1 is linked to small cell lung carcinoma.